SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001583648-18-000068
Filing Date
2018-10-25
Accepted
2018-10-25 08:31:17
Documents
5
Period of Report
2018-10-25
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm 8-K 28187
2 EXHIBIT 99.1 a181025pierispressreleas.htm EX-99.1 7316
3 a181025pierispressreleas001.jpg GRAPHIC 260920
4 a181025pierispressreleas002.jpg GRAPHIC 241872
5 a181025pierispressreleas003.jpg GRAPHIC 15343
  Complete submission text file 0001583648-18-000068.txt   750843
Mailing Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109
Business Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109 857-246-8998
PIERIS PHARMACEUTICALS, INC. (Filer) CIK: 0001583648 (see all company filings)

IRS No.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37471 | Film No.: 181137717
SIC: 8731 Services-Commercial Physical & Biological Research
Assistant Director 9